Entecavir Achieves High Response Rate In Real-life Clinical Management Of Patients With Chronic Hepatitis B
Links shared publicly online about this topic.
- 1,626total visits
Entecavir Achieves High Response Rate In Real-life Clinical Management Of Patients With Chronic Hepatitis B
The nucleoside analogue entecavir (baraclude, bristol-myers squibb) achieves a high response rate and progressive decline in liver stiffness in patients with chronic hepatitis b, according to res
View full resource at medicalnewstoday.com
Tags: Liver, Liver Condition, Hepatitis, Hepatitis B, Hepatitis B Medication, Baraclude, Bristol-Myers Squibb
Most Recently Shared on November 4, 2009 at 9:31 pm By:
#HEALTH Entecavir Achieves High Response Rate In Reallife Clinical Management Of Patients With Chronic Hepatitis B http://ow.ly/15Zst8
Also Shared By:
Advertisement
MNT Health News
@mnt_healthnews
Entecavir Achieves High Response Rate In Real-life Clinical Management Of Patients With Chronic He.. http://bit.ly/3E8wTh #health_news
1 year ago...